- The Indirect Psychological Costs of Cognitive Enhancement.Nadira Faulmüller, Hannah Maslen & Filippo Santoni de Sio - 2013 - American Journal of Bioethics 13 (7):45-47.details
|
|
Public Attitudes Toward Cognitive Enhancement.Nicholas Fitz, Roland Nadler, Praveena Manogaran, Eugene Chong & Peter Reiner - 2013 - Neuroethics 7 (2):173-188.details
|
|
Exploring Some Challenges of the Pharmaceutical Cognitive Enhancement Discourse: Users and Policy Recommendations.Toni Pustovrh & Franc Mali - 2013 - Neuroethics 7 (2):137-158.details
|
|
Public Opinion on Cognitive Enhancement Varies across Different Situations.Claire T. Dinh, Stacey Humphries & Anjan Chatterjee - 2020 - American Journal of Bioethics Neuroscience 11 (4):224-237.details
|
|
“It Was Me on a Good Day”: Exploring the Smart Drug Use Phenomenon in England.Elisabeth J. Vargo & Andrea Petróczi - 2016 - Frontiers in Psychology 7.details
|
|
The is and ought of the Ethics of Neuroenhancement: Mind the Gap.Cynthia Forlini & Wayne Hall - 2015 - Frontiers in Psychology 6.details
|
|
A Comparison of Attitudes Toward Pharmacological Treatment Versus Enhancement Under Competitive and Noncompetitive Conditions.Jeffrey M. Rudski - 2014 - AJOB Empirical Bioethics 5 (2):80-90.details
|
|
If you’re smart, we’ll make you smarter: Applying the reasoning behind the development of honours programmes to other forms of cognitive enhancement.Bas Olthof, Anco Peeters, Kimberly Schelle & Pim Haselager - 2013 - In Federica Lucivero & Anton Vedder (eds.), Beyond Therapy v. Enhancement? Multidisciplinary analyses of a heated debate. Pisa University Press. pp. 117-142.details
|
|
Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement.Sebastian Sattler & Reinhard Schunck - 2015 - Frontiers in Psychology 6.details
|
|
Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical-Ethical Analysis.Cynthia Forlini, Jan Schildmann, Patrik Roser, Radim Beranek & Jochen Vollmann - 2014 - Neuroethics 8 (2):83-92.details
|
|
Attitudes Toward Cognitive Enhancement: The Role of Metaphor and Context.Erin C. Conrad, Stacey Humphries & Anjan Chatterjee - 2019 - American Journal of Bioethics Neuroscience 10 (1):35-47.details
|
|
Pharmacological Cognitive Enhancement: Examining the Ethical Principles Guiding College Students’ Abstention.Niloofar Bavarian, Stephanie Sumstine, Jocelyne Mendez, Kyle Yomogida, Wilma Figueroa & Cammie Lam - 2018 - Neuroethics 12 (3):271-278.details
|
|
Reasons for Comfort and Discomfort with Pharmacological Enhancement of Cognitive, Affective, and Social Domains.Laura Y. Cabrera, Nicholas S. Fitz & Peter B. Reiner - 2014 - Neuroethics 8 (2):93-106.details
|
|
Regulating Methylphenidate: Enhancing Cognition and Social Inequality.C. D. Brewer & Heather DeGrote - 2013 - American Journal of Bioethics 13 (7):47-49.details
|
|
Cognitive Enhancement vs. Plagiarism: a Quantitative Study on the Attitudes of an Italian Sample.Lorenzo Palamenghi & Claudia Bonfiglioli - 2019 - Neuroethics 12 (3):279-292.details
|
|
Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities.Meghana Kasturi Vagwala, Aude Bicquelet, Gabija Didziokaite, Ross Coomber, Oonagh Corrigan & Ilina Singh - 2017 - Neuroethics 10 (3):389-403.details
|
|
Context-Dependent Risk & Benefit Sensitivity Mediate Judgments About Cognitive Enhancement.Kiante Fernandez, Roy Hamilton, Laura Cabrera & John Dominic Medaglia - 2022 - American Journal of Bioethics Neuroscience 13 (1):73-77.details
|
|